- E-postAnette.Boe@uib.no
- Telefon+47 55 58 53 66+47 916 23 378
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget
- PostadressePostboks 78045020 Bergen
Bøker
- 2019. Thymus transcriptome and Cell biology; Chapter 8. Springer. 300 sider. ISBN: 978-3-030-12039-9.
- 1995. Hyperbaric medical emergency service. Evaluation of equipment, procedures and techniques. NUTEC Report 5-95. 23 sider.
Tidsskriftartikler
- 2019. Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. Frontiers in Endocrinology. 10:648: 1-5. doi: 10.3389/fendo.2019.00648
- 2019. Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. Journal of translational autoimmunity.
- 2018. Oral microbiota in autoimmune polyendocrine syndrome type 1. Journal of Oral Microbiology. 10:1442986: 1-10. doi: 10.1080/20002297.2018.1442986
- 2017. Altered immune activation and IL-23 signaling in response to Candida albicans in autoimmune polyendocrine syndrome type 1. Frontiers in Immunology. 8:1074: 1-10. doi: 10.3389/fimmu.2017.01074
- 2017. Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins. Frontiers in Immunology. 8. doi: 10.3389/fimmu.2017.00976
- 2017. Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins. Frontiers in Immunology. 8. doi: 10.3389/fimmu.2017.00976
- 2017. Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I. Autoimmunity. 50: 211-222. doi: 10.1080/08916934.2017.1344972
- 2017. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1. Journal of Pediatric Endocrinology & Metabolism (JPEM). 102: 3546-3556. doi: 10.1210/jc.2017-00139
- 2016. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 101: 2975-2983. doi: 10.1210/jc.2016-1821
- 2016. AIRE-mutations and autoimmune disease. Current Opinion in Immunology. 43: 8-15. doi: 10.1016/j.coi.2016.07.003
- 2016. AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies. Cell. 166: 582-595. doi: 10.1016/j.cell.2016.06.024
- 2015. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. Endocrine Connections. 4: 215-222. doi: 10.1530/EC-15-0066
- 2015. Linkage analysis in autoimmune Addison's disease: NFATC1 as a potential novel susceptibility locus. PLOS ONE. 10:e0123550. doi: 10.1371/journal.pone.0123550
- 2015. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 42: 1185-1196. doi: 10.1016/j.immuni.2015.04.021
- 2015. CTLA-4 as a genetic determinant in autoimmune Addison's disease. Genes and Immunity. 16: 430-436. doi: 10.1038/gene.2015.27
- 2014. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. Clinical Immunology. 153: 220-227. doi: 10.1016/j.clim.2014.04.013
- 2014. Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocrine Connections. 15: 67-74. doi: 10.1530/EC-14-0032
- 2014. CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. European Journal of Endocrinology. 171: 743-750. doi: 10.1530/EJE-14-0432
- 2014. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. PLOS ONE. 9. doi: 10.1371/journal.pone.0088991
- 2014. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. Journal of Immunology. 193: 3880-3890. doi: 10.4049/jimmunol.1401068
- 2013. Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. Immunobiology. 218: 899-909. doi: 10.1016/j.imbio.2012.10.006
- 2013. Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 77: 310-310.
- 2013. Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease. Clinical Endocrinology. 79: 316-320. doi: 10.1111/cen.12159
- 2013. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clinical and Experimental Immunology. 171: 263-272. doi: 10.1111/cei.12024
- 2013. Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. Scandinavian Journal of Immunology. 77: 306-307.
- 2013. Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. Experimental and clinical endocrinology & diabetes. 121. 2 sider. doi: 10.1055/s-0033-1336696
- 2013. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. Journal of Clinical Immunology. 33: 1341-1348. doi: 10.1007/s10875-013-9938-6
- 2012. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 32: 230-237. doi: 10.1007/s10875-011-9617-4
- 2012. Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. Journal of Clinical Endocrinology and Metabolism. 97: 1114-1124. doi: 10.1210/jc.2011-2461
- 2012. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyedocrine sydnrome type I. Immunology. 137: 673-674.
- 2012. Increased anti-cytokine autoantibodies without disease manifestion in a 4 year-old boy with autoimmune polyendocrine syndrome )APS)-1. Journal of Clinical Immunology. 32: 110-111.
- 2012. Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. Immunology. 137: 211-212.
- 2011. Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. BMC Medical Genetics. 12. 6 sider. doi: 10.1186/1471-2350-12-111
- 2011. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. European Journal of Endocrinology. 165: 345-352. doi: 10.1530/EJE-10-1206
- 2011. Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. Scandinavian Journal of Immunology. 74: 327-333. doi: 10.1111/j.1365-3083.2011.02573.x
- 2011. Multiple loci in the HLA complex are associated with Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 96: E1703-E1708. doi: 10.1210/jc.2011-0645
- 2011. Cytokine Antibodies in Autoimmune Polyendocrine Syndrome Type I Correlates to Chronic candidiasis. Scandinavian Journal of Immunology. 73: 379-379.
- 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. Journal of Experimental Medicine. 207: 299-308. doi: 10.1084/jem.20091669
- 2010. Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). Scandinavian Journal of Immunology. 71: 493-494.
- 2010. Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. Clinical Endocrinology. 72: 641-647. doi: 10.1111/j.1365-2265.2009.03740.x
- 2010. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scandinavian Journal of Immunology. 71: 459-467. doi: 10.1111/j.1365-3083.2010.02397.x
- 2009. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. Journal of Clinical Endocrinology and Metabolism. 94: 4882-4890. doi: 10.1210/jc.2009-1368
- 2009. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. European Journal of Endocrinology. 160: 993-1002. doi: 10.1530/EJE-08-0880
- 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity. 10: 120-124. doi: 10.1038/gene.2008.85
- 2009. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. Journal of Clinical Endocrinology and Metabolism. 94: 5139-5145. doi: 10.1210/jc.2009-1404
- 2009. Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility. Journal of Clinical Endocrinology and Metabolism. 94: 5139-5145. doi: 10.1210/jc.2009-1404
- 2008. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 112: 2657-2666. doi: 10.1182/blood-2008-03-144634
- 2008. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. European Journal of Endocrinology. 158: 705-709. doi: 10.1530/EJE-07-0843
- 2008. Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. Journal of Clinical Endocrinology and Metabolism. 93: 4389-4397. doi: 10.1210/jc.2008-0935
- 2008. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology. 129: 163-169. doi: 10.1016/j.clim.2008.07.002
- 2008. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. European Journal of Human Genetics. 16: 977-982. doi: 10.1038/ejhg.2008.33
- 2008. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism. 93: 3310-3317. doi: 10.1210/jc.2008-0821
- 2008. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes and Immunity. 9: 130-136. doi: 10.1038/sj.gene.6364457
- 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Biochemical and Biophysical Research Communications - BBRC. 353: 692-698. doi: 10.1016/j.bbrc.2006.12.080
- 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Scandinavian Journal of Immunology. 65: 592-592.
- 2007. Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. Journal of Clinical Endocrinology and Metabolism. 92: 595-603. doi: 10.1210/jc.2006-1873
- 2007. Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scandinavian Journal of Immunology. 65: 555-558. doi: 10.1111/j.1365-3083.2007.01932.x
- 2004. Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. British Journal of Cancer. 91: 1508-1514.
- 2004. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. European Journal of Endocrinology. 150: 49-56.
- 2000. Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. Clinical and Experimental Immunology. 120: 420-423.
- 1996. Lumbale skiveprolapser hos ungdom. Tidsskrift for Den norske legeforening. 116: 2993-2995.
- 1996. Open tibial fractures treated with the Ex-fi-re external system. Clinical Orthopaedics and Related Research. 326: 209-220.
- 1992. Albueartroskopi. Tidsskrift for Den norske legeforening. 493-494.
Rapporter/avhandlinger
- 2014. Samhandling mellom Røde Kors Haugland Rehabiliteringssenter, NAV og primærhelsetenesta i heile rehabiliteringsforløpet. Røde Kors Haugland Rehabiliteringssenter, Flekke. 39 sider.
- 2005. Immunological perspectives of autoimmune polyendocrine syndromes and cancer.
Bokkapitler
- 2019. Aire Mutations and Autoimmune Diseases. 8, sider 191-214. I:
- 2019. Thymus transcriptome and Cell biology; Chapter 8. Springer. 300 sider. ISBN: 978-3-030-12039-9.
- 2019. Polyendocrine disorders and endocrine neoplastic syndromes Chapter 2-1 "The Natural History of APS1. Chapter 2-1, sider . I:
- 2019. Polyendocrine Disorders and Endocrine Neoplastic Syndromes. 200 sider. ISBN: 978-3-319-73082-0.